FDA Inspection 1240128 — Smith's Layton Distribution Center

Smith's Layton Distribution Center — FEI 1717324

The FDA completed an inspection of Smith's Layton Distribution Center on May 13, 2024 in Layton, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 13, 2024
Fiscal Year
2024
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Layton, UT (United States)